Claudin-low breast cancers: clinical, pathological, molecular and prognostic characterization
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Claudin-low breast cancers: clinical, pathological, molecular and prognostic characterization
Authors
Keywords
Breast cancer, Claudin-low, Molecular profiling, Prognosis, Response to chemotherapy
Journal
Molecular Cancer
Volume 13, Issue 1, Pages 228
Publisher
Springer Nature
Online
2014-10-02
DOI
10.1186/1476-4598-13-228
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The current state of breast cancer classification
- (2012) G. Viale ANNALS OF ONCOLOGY
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Basal Breast Cancer: A Complex and Deadly Molecular Subtype
- (2011) F. Bertucci et al. CURRENT MOLECULAR MEDICINE
- A Genomic Predictor of Response and Survival Following Taxane-Anthracycline Chemotherapy for Invasive Breast Cancer
- (2011) Christos Hatzis JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Multifactorial Approach to Predicting Resistance to Anthracyclines
- (2011) Christine Desmedt et al. JOURNAL OF CLINICAL ONCOLOGY
- Kinome expression profiling and prognosis of basal breast cancers
- (2011) Renaud Sabatier et al. Molecular Cancer
- A refined molecular taxonomy of breast cancer
- (2011) M Guedj et al. ONCOGENE
- Evaluation of a 30-Gene Paclitaxel, Fluorouracil, Doxorubicin, and Cyclophosphamide Chemotherapy Response Predictor in a Multicenter Randomized Trial in Breast Cancer
- (2010) A. Tabchy et al. CLINICAL CANCER RESEARCH
- Efficacy of Neoadjuvant Cisplatin in Triple-Negative Breast Cancer
- (2010) Daniel P. Silver et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular Anatomy of Breast Cancer Stroma and Its Prognostic Value in Estrogen Receptor–Positive and –Negative Cancers
- (2010) Giampaolo Bianchini et al. JOURNAL OF CLINICAL ONCOLOGY
- Intratumor Heterogeneity and Precision of Microarray-Based Predictors of Breast Cancer Biology and Clinical Outcome
- (2010) William T. Barry et al. JOURNAL OF CLINICAL ONCOLOGY
- Gene Pathways Associated With Prognosis and Chemotherapy Sensitivity in Molecular Subtypes of Breast Cancer
- (2010) Takayuki Iwamoto et al. JNCI-Journal of the National Cancer Institute
- A pathway-based classification of human breast cancer
- (2010) M. L. Gatza et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes
- (2010) J. H. Taube et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Gene expression pathway analysis to predict response to neoadjuvant docetaxel and capecitabine for breast cancer
- (2009) Larissa A. Korde et al. BREAST CANCER RESEARCH AND TREATMENT
- Proliferative genes dominate malignancy-risk gene signature in histologically-normal breast tissue
- (2009) Dung-Tsa Chen et al. BREAST CANCER RESEARCH AND TREATMENT
- In vivo Antitumor Activity of MEK and Phosphatidylinositol 3-Kinase Inhibitors in Basal-Like Breast Cancer Models
- (2009) K. P. Hoeflich et al. CLINICAL CANCER RESEARCH
- Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
- (2009) Joel S. Parker et al. JOURNAL OF CLINICAL ONCOLOGY
- Genes that mediate breast cancer metastasis to the brain
- (2009) Paula D. Bos et al. NATURE
- A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer
- (2009) Pierre Farmer et al. NATURE MEDICINE
- Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers
- (2009) Elgene Lim et al. NATURE MEDICINE
- A Core MYC Gene Expression Signature Is Prominent in Basal-Like Breast Cancer but Only Partially Overlaps the Core Serum Response
- (2009) Sanjay Chandriani et al. PLoS One
- Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
- (2009) C. J. Creighton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy
- (2008) Yi Zhang et al. BREAST CANCER RESEARCH AND TREATMENT
- The Humoral Immune System Has a Key Prognostic Impact in Node-Negative Breast Cancer
- (2008) M. Schmidt et al. CANCER RESEARCH
- A Precisely Regulated Gene Expression Cassette Potently Modulates Metastasis and Survival in Multiple Solid Cancers
- (2008) Kun Yu et al. PLoS Genetics
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now